Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1989-4-10
|
| pubmed:abstractText |
A prospective 2-phase study was performed on 24 patients with locally advanced transitional cell carcinoma of the urinary bladder to evaluate the toxicity of integrated treatment with Adriamycin 10 mg/m2 (group A) or 20 mg/m2 (group B) and hyperfractionated, accelerated radiotherapy. Local and systemic toxicity with Adriamycin 10 mg/m2 was significantly lower than with 20 mg/m2. Complete tumour remission was achieved in 18 patients (6 of 8 patients in group A and 12 of 16 in group B). In 12 cases the treatment could be stopped after the first series.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0007-1331
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
63
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
64-7
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:2920262-Carcinoma, Transitional Cell,
pubmed-meshheading:2920262-Combined Modality Therapy,
pubmed-meshheading:2920262-Doxorubicin,
pubmed-meshheading:2920262-Female,
pubmed-meshheading:2920262-Humans,
pubmed-meshheading:2920262-Male,
pubmed-meshheading:2920262-Prospective Studies,
pubmed-meshheading:2920262-Urinary Bladder Neoplasms
|
| pubmed:year |
1989
|
| pubmed:articleTitle |
Concurrent adriamycin and radiotherapy in locally advanced bladder cancer.
|
| pubmed:affiliation |
Department of Urology, University of Innsbruck, Austria.
|
| pubmed:publicationType |
Journal Article
|